Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Trading lectures for active learning opportunities is gaining momentum across U.S. medical schools, according to an April 2 article from the Association of American Medical Colleges. Active learning ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

New York Times bestselling author John Green will deliver Drake University's 47th Annual Bucksbaum Distinguished Lectureship on Thursday, April 2. Starting at 7 p.m. in the Knapp Center on Drake’s ...

"Where ETH meets the world." The Global Lecture Series brings the world’s leading minds to ETH Zurich to explore ideas that shape our global future. Through thought-provoking dialogue and diverse ...

Behind the following links are lecturebook examples that focus on single concepts. These examples have been primarily taken from exams from past semesters, and have considerable relevance to you as ...

A top Vatican diplomat was summoned to the Pentagon to receive a “bitter lecture” about supporting President Donald Trump’s warmongering, a new report alleges. Vatican officials briefed on the meeting ...

Wanna see a trick? Give us any topic and we can tie it back to the economy. At Planet Money, we explore the forces that shape our lives and bring you along for the ride. Don't just understand the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...